Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025European Journal of Hospital PharmacyOpen Access

Enhancing depression management in older cancer patients: the pharmacist’s role

View Full Paper
Ask AI
Bookmark
Share

Authors

RJRojita JadhariNPNabin PathakSDShreya Dhungana

Discussion

Loading...

Member takes

Overview

Systematic review reveals gaps in pharmacist involvement in pharmacological interventions for older cancer patients with depression, implying a need for targeted research.

Key Points

  • Pharmacist involvement in depression treatment enhances quality of life in older cancer patients.
  • About 10–20% of cancer patients experience depression, highlighting a significant public health issue.
  • Depression in older cancer patients often complicates treatment, leading to higher mortality rates due to medication interactions.
  • Major gaps exist in research on pharmacological interventions for this vulnerable population.

Cite This Study

Jadhari et al. (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478be2bhttps://doi.org/10.1136/ejhpharm-2025-004682
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatments of depressive symptoms in cancer patients: A systematic review and network meta-analysis2025
  2. 2Pharmacist-led deprescribing in older adults with cancer in ambulatory clinics: A sustainable QI initiative.2025
  3. 3Association Between Depression and Polypharmacy in Older Adults—A Systematic Review and Meta‐Analysis2026
  4. 4Impact of Pharmacist-Led Deprescribing Interventions on Medication Related Outcomes Among Older Adults: A Systematic Review and Meta-analysis2025 · 1 citations
  5. 5The Hidden Struggle: Depression Among Seniors2025